Empiema
[Empyema: An Update Approach]
Downloads
Empyema is a collection of exudative fluid in the pleural cavity associated with the occurrence of pulmonary infection. Empyema is often caused by complications of pneumonia but can also be caused by infection from elsewhere. Community-aquired pneumonia has an incidence of 8 to 15 per 1000 per year. Forty to 57% of patients with pneumonia, may develop into a parapneumonic effusion. Approximately 5 to 10% of parapneumonic effusions develop into empyema. All patients with parapneumonia and empyema effusions require antibiotic therapy early and adequate. Sterile pleural effusions with PH ≥ 7,20 were observed and protected by adequate antibiotics. Empyema and localized pleural effusions and parapneumonic effusions with PH <7.20 or glucose <60 mg / dL or the presence of germs on positive examination and culture require drainage. Delays in drainage may increase morbidity and mortality rates. Management of empyema depending on the stage, antibiotics or thoracocentesis, thoracostomy, thoracostomy with fibrinolytic therapy, thoracoscopy, dekortication and open thoracotomy.
Davies HE, Davies RJ, Davies CW. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax. 2010; 65(suppl 2): 41-53
Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007; 45: 1480-1486.
Strachan RE, Gulliver T, Martin A, McDonald T, Nixon G, Roseby R, et.al. Pediatric Empyema Thoracis: Recommendation for Management. The Thoracic Society of Australia and New Zealand. 2011: 1-39.
Sharma S. Empyema, pleuropulmonary. Available at: http://www. emedicine.com/med/topic659.htm. Accesed on June 23 rd, 2008.
Garrido VV, Sancho JF, Blasco LH, Gafas AP, et al. Diagnosis and treatment of pleural effusion. Arch Bronkoneumol. 2006; 42(7): 349-372.
Heffne JE, Klein JS, Hampson C. Interventional management of pleural infections. Chest. 2009; 136(4); 1148-1159.
Koegelenberg CF, Diaconb AH, Chris T, Bolligere CT. Parapneumonic pleural effusion and empyema. Respiration. 2008; 75(3); 241-250.
Light RW. Parapneumonic effusions and empyema. Pleural disease. 3rd ed. Baltimore: Williams & Wilkins, 1995; 129-153.
Light RW, Lee YG. Textbook of Pleural Disease. 2nd edition. UK. Hudder Arnold. 2008: 26; 341-362.
Vianna NS. Non tuberculous bacterial empyema in patient with and without underlying diseases. J. Am. Med Assoc. 1971: 215: 69-75.
Rogayah, Rita. Empiema. 2010. Jakarta: Dept. Pulmonologi dan Ilmu Kedokteran Respirasi FKUI. Diakses tanggal 27 Mei 2013: http:// staff.ui.ac.id/internal/140240448/material/empiema.pdf
Strachan RE, Gulliver T, Martin A, McDonald T, Nixon G, Roseby R, et.al. Pediatric Empyema Thoracis: Recommendation for Management. The Thoracic Society of Australia and New Zealand. 2011: 1-39.
Helen E Davies, Robert J O Davies, on behalf of the BTS Pleural Disease Guidline Group. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65(Suppl 2): 41-53. Garrido VV, Sancho JF, Blasco LH, Gafas AP, et al. Diagnosis and treatment of pleural effusion. Arch Bronkoneumol. 2006; 42: 349-372.
Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evi- dence-based guideline. Chest 2000; 118: 1158-1171
Rahman NM, Chapman SJ, Davis RJO. Pleural effusion: A structured approach to care. British Medical Bullein. 2005; 72: 31-47.
Banga A, Khilnani GC, Sharma SK, Dey AB, Wig N, Banga N. A study of empiema thoracis and role of intrapleural streptokinase in its management. BMC Infectious Diseases. 2004; 4: 9-18.
Acharya PR, Shah KV. Empyema thoracis: A clinical study. Ann Thorac Med. 2007; 2: 14-7.
Andrews NC, Parker EF, Shaw RP, et al. Management of nontuberculous empyema. A statement of the sub-committee on surgery. Am Rev Respir Dis 1962; 85: 935-936.
Andrews NC, Parker EF, Shaw RP, et al. Management of nontuberculous empyema. A statement of the sub- committee on surgery. Am Rev Respir Dis 1962; 85: 935-936.
Copyright (c) 2018 Helmia Hasan, Devi Ambarwati
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.